CAPR — Capricor Therapeutics Share News
0.000.00%
Last trade - 00:00- $356.39m
- $118.46m
Capricor's muscle disorder cell therapy succeeds in late-stage study (updated)
Capricor Therapeutics' muscle disorder cell therapy succeeds in late-stage study
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:15 AM
Capricor Therapeutics Q3 net loss widens
Brief: Capricor Therapeutics Q3 EPS USD -0.54
Capricor climbs as FDA clears path for resubmission of cell therapy application
Brief: Capricor Therapeutics Provides Regulatory Update on Deramiocel Program for Duchenne Muscular Dystrophy Following Type A Meeting
Brief: Capricor Therapeutics Files For Mixed Shelf Offering Of Up To $300 Million- SEC Filing
U.S. STOCKS ON THE MOVE-Anavex Life Sciences, Oil companies, Yum! Brands
U.S. STOCKS ON THE MOVE-Anavex Life Sciences, oil companies, Yum Brands
Capricor Therapeutics down after responding to FDA's 'complete response letter'
Capricor Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-Elf Beauty, Intel, Archer Aviation
U.S. STOCKS ON THE MOVE-Duke Energy, Paramount, WW International
U.S. STOCKS ON THE MOVE-Bancorp, pot stocks, Avantor
Gene therapy developers fall after Vinay Prasad reinstated as FDA's top vaccine official
Capricor Therapeutics Inc expected to post a loss of 47 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Centrus Energy, Tempus AI, Hagerty
U.S. STOCKS ON THE MOVE-Under Armour, Pinterest, Take-Two Interactive